Gene: C2orf16
Official Full Name: SPATA31 subfamily H member 1provided by HGNC
Gene Summary: Located in extracellular exosome and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25085 | C2orf16 Knockout cell line (A549) | Human | C2orf16 | 1:3~1:4 | Negative | Online Inquiry |
C2orf16 Gene Knockout Cell Lines are genetically engineered cell lines in which the C2orf16 gene has been systematically disrupted or "knocked out." This innovative product serves as a valuable tool for researchers investigating the functional roles of the C2orf16 gene in cellular processes, particularly those linked to human diseases where this gene has shown to have potential implications. The knockout mechanism typically involves CRISPR-Cas9 technology, which enables precise editing of the genome, leading to a complete loss of gene function.
The primary function of C2orf16 Gene Knockout Cell Lines is to facilitate in-depth studies of gene function, uncovering the biological pathways influenced by the C2orf16 gene. These cell lines allow researchers to observe the phenotypic consequences of gene knockout, offering insights into gene interactions and potential compensatory mechanisms within cellular networks. In clinical settings, such models are invaluable for understanding the genetic underpinnings of various diseases, including some cancers and metabolic disorders.
C2orf16 Gene Knockout Cell Lines set themselves apart from traditional methods through their unparalleled specificity and efficiency. Unlike random mutagenesis approaches, CRISPR technology offers targeted alterations that minimize off-target effects, leading to more reliable and reproducible results. This specificity allows for a streamlined path of inquiry for researchers, enhancing both productivity and timeliness in experiments.
For researchers and clinicians, the availability of these knockout cell lines presents a significant advantage in drug development and therapeutic explorations. They provide a robust platform for screening and validating potential drug candidates aimed at modulating outcomes associated with C2orf16 gene expression.
Our company prides itself on delivering high-quality genetic models, developed through rigorous scientific protocols and extensive validation. With a deep understanding of molecular biology and genetics, we are committed to supporting research communities with innovative solutions that foster discovery and advancement in genetic research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.